LOX and prostate neoplasm: Inversely, LOX mRNA expression was decreased in metastatic compared to primary prostate tumors [36] and low levels of LOX expression have also been reported in high-grade tumors [37, 38], suggesting loss of LOX expression during prostate tumor progression.